Contribution: Industrial Research Assistance Program – Contributions to Firms
Eupraxia Pharmaceuticals Inc.
$700,000.00
Determination of polymer disposition and safety after drug product administration
EF 2021-22 · 2021-09-01
Résumé
This project will determine the safety, metabolism and clearance of the novel coating, in particular the polymer component, of the firm's extended-release technology platform through in vivo studies to identify the mode and rate of elimination of the coating from the body after administration.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Victoria|Victoria, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
818717308
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2023-12-15
Agreement Number
979716
Agreement Start Date
2021-09-01
Agreement Title
Determination of polymer disposition and safety after drug product administration
Agreement Title (French)
Détermination de la disposition et de la sécurité des polymères après l'administration d'un produit pharmaceutique
Agreement Type
Contribution
Agreement Value
$700,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will determine the safety, metabolism and clearance of the novel coating, in particular the polymer component, of the firm's extended-release technology platform through in vivo studies to identify the mode and rate of elimination of the coating from the body after administration.
Description (French)
Ce projet permettra de déterminer la sécurité, le métabolisme et la libération du nouvel enrobage, en particulier le composant polymère, de la plateforme technologique à libération prolongée de l'entreprise par le biais d'études in vivo visant à déterminer le mode et le taux d'élimination de l'enrobage de l'organisme après administration.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Victoria
Federal Riding (French)
Victoria
Federal Riding Number
59041
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
818717308
Recipient City
Victoria|Victoria
Recipient Country
CA
Recipient Legal Name
Eupraxia Pharmaceuticals Inc.
Recipient Postal Code
V8R 5G4
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q3-979716
